Hermine Poghosyan1, Susan Mello, Kathryn N Robinson, Andy S L Tan. 1. Author Affiliations: School of Nursing, Bouve College of Health Sciences (Dr Poghosyan), and Communication Studies (Dr Mello), Northeastern University, Boston, Massachusetts; School of Nursing, University of Maine, Orono (Dr Robinson); and Department of Social and Behavioral Sciences, Harvard T. H. Chan School of Public Health, Boston, Massachusetts (Dr Tan).
Abstract
BACKGROUND: Early diagnosis of lung cancer is key to improving the long-term prognosis for many individuals. Still, utilization rates of lung cancer screening (LCS) remain low. OBJECTIVE: To investigate the association between worry about future health issues of smoking and intention to undergo recommended LCS with low-dose computed tomography (LDCT) within the next 3 months. METHODS: A cross-sectional online survey was conducted using the Qualtrics Panel to recruit adult smokers between ages 54 and 75 years, with no history of lung cancer, and at least 30-pack-year smoking history (n = 152). The survey gathered demographic, socioeconomic, and psychographic information, including intention to screen for lung cancer with LDCT and worry about the future health issues of smoking. Data were analyzed using multivariable logistic regression. RESULTS: Approximately 43.0% were White, 21.7% were Black, and 60.0% were female. Most (86.0%) reported intentions to undergo recommended LCS with LDCT in the next 3 months. More than one-third (32.0%) reported moderately/very worried about the future health issues of smoking. Smokers who were moderately/very worried had 20% (P = .022) higher odds of reporting an intention to undergo LCS with LDCT than those who were not at all or a little worried. CONCLUSIONS: Most eligible adults reported intentions to undergo LCS with LDCT. Our study also highlights sex, racial, and socioeconomic differences in LCS behavior. IMPLICATIONS FOR PRACTICE: The study findings provide an opportunity for healthcare providers to have in-depth discussions about the benefits of LCS with those who express worry about future health issues of smoking.
BACKGROUND: Early diagnosis of lung cancer is key to improving the long-term prognosis for many individuals. Still, utilization rates of lung cancer screening (LCS) remain low. OBJECTIVE: To investigate the association between worry about future health issues of smoking and intention to undergo recommended LCS with low-dose computed tomography (LDCT) within the next 3 months. METHODS: A cross-sectional online survey was conducted using the Qualtrics Panel to recruit adult smokers between ages 54 and 75 years, with no history of lung cancer, and at least 30-pack-year smoking history (n = 152). The survey gathered demographic, socioeconomic, and psychographic information, including intention to screen for lung cancer with LDCT and worry about the future health issues of smoking. Data were analyzed using multivariable logistic regression. RESULTS: Approximately 43.0% were White, 21.7% were Black, and 60.0% were female. Most (86.0%) reported intentions to undergo recommended LCS with LDCT in the next 3 months. More than one-third (32.0%) reported moderately/very worried about the future health issues of smoking. Smokers who were moderately/very worried had 20% (P = .022) higher odds of reporting an intention to undergo LCS with LDCT than those who were not at all or a little worried. CONCLUSIONS: Most eligible adults reported intentions to undergo LCS with LDCT. Our study also highlights sex, racial, and socioeconomic differences in LCS behavior. IMPLICATIONS FOR PRACTICE: The study findings provide an opportunity for healthcare providers to have in-depth discussions about the benefits of LCS with those who express worry about future health issues of smoking.
Authors: Gary X Wang; Travis P Baggett; Pari V Pandharipande; Elyse R Park; Sanja Percac-Lima; Jo-Anne O Shepard; Florian J Fintelmann; Efren J Flores Journal: Radiology Date: 2019-01-08 Impact factor: 11.105
Authors: Vani N Simmons; Jhanelle E Gray; Matthew B Schabath; Lauren E Wilson; Gwendolyn P Quinn Journal: Lung Cancer Date: 2017-01-31 Impact factor: 5.705
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Sirisha Jonnalagadda; Cara Bergamo; Jenny J Lin; Linda Lurslurchachai; Michael Diefenbach; Cardinale Smith; Judith E Nelson; Juan P Wisnivesky Journal: Lung Cancer Date: 2012-06-06 Impact factor: 5.705
Authors: Lovoria B Williams; Stephen W Looney; Thomas Joshua; Amber McCall; Martha S Tingen Journal: Cancer Nurs Date: 2021 Mar-Apr 01 Impact factor: 2.592